MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma

Nanotechnology

Volumn 19, Issue 31, 2008, Pages

  Karathanasis, Efstathios ^a   Park, Jaekeun ^a,b   Agarwal, Abhiruchi ^a   Patel, Vijal ^a   Zhao, Fuqiang ^a,b   Annapragada, Ananth V ^c   Hu, Xiaoping ^a,b   Bellamkonda, Ravi V ^a  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; GADOLINIUM; IMAGING TECHNIQUES; LAWS AND LEGISLATION; MAGNETIC FIELDS; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; ONCOLOGY; RESONANCE;

BLOOD BRAIN BARRIER (BBB); BLOOD CIRCULATION; BRAIN TUMORS; CONTRAST AGENT (CA); CONTRAST-ENHANCED; GADOLINIUM BASED CONTRAST AGENT; GLIOMA MODEL; HIGH RESOLUTIONS; INDIVIDUAL (PSS 544-7); MAGNETIC (CE); NANO CARRIER; NANOCARRIERS; NON INVASIVE; PATIENT SPECIFIC; SURGICAL PLANNING; TUMOR RESECTION; VASCULAR PERMEABILITY; VASCULATURE; WIDE-RANGE;

TUMORS;

GADODIAMIDE; LIPOSOME; NANOCARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; CANCER MODEL; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; GLIOMA; HISTOPATHOLOGY; IMAGE QUALITY; IMAGING SYSTEM; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETISM; MALE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

EID: 47249102883     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/19/31/315101     Document Type: Article

References (51)

1. Arnold R D, Mager D E, Slack J E and Straubinger R M 2005 Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model Clin. Cancer Res. 11 8856-65
2. Ayyagari A L, Zhang X, Ghaghada K B, Annapragada A, Hu X and Bellamkonda R V 2006 Long-circulating liposomal contrast agents for magnetic resonance imaging Magn. Reson. Med. 55 1023-9
3. Barker F G 2nd, Chang S M, Gutin P H, Malec M K, McDermott M W, Prados M D and Wilson C B 1998 Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 709-20 discussion 20-3
4. Black K L and Pikul B K 1999 Gliomas-past, present, and future Clin. Neurosurg. 45 160-3
5. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S and Griebel J 2004 Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series Magn. Reson. Med. 52 420-9
6. Daldrup H, Shames D M, Wendland M, Okuhata Y, Link T M, Rosenau W, Lu Y and Brasch R C 1998 Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media AJR Am. J. Roentgenol. 171 941-9
7. Damert A, Machein M, Breier G, Fujita M Q, Hanahan D, Risau W and Plate K H 1997 Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms Cancer Res. 57 3860-4
8. Erdogan S, Medarova Z O, Roby A, Moore A and Torchilin V P 2008 Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes J. Magn. Reson. Imaging 27 574-80
9. Erdogan S, Roby A, Sawant R, Hurley J and Torchilin V P 2006 Gadolinium-loaded polychelating polymer-containing cancer cell-specific immunoliposomes J. Liposome Res. 16 45-55
10. Ferrari M 2005 Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 161-71
11. Fine H A, Dear K B, Loeffler J S, Black P M and Canellos G P 1993 Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 2585-97
12. Fukumura D and Jain R K 2007 Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize J. Cell. Biochem. 101 937-49
13. Furman-Haran E and Degani H 2002 Parametric analysis of breast MRI J. Comput. Assist. Tomogr. 26 376-86
14. Ghaghada K B, Bockhorst K H, Mukundan S Jr, Annapragada A V and Narayana P A 2007 High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent AJNR Am. J. Neuroradiol 28 48-53
15. Heath J R and Davis M E 2007 Nanotechnology and Cancer Annu. Rev. Med. 59 251-65
16. Hobbs S K, Monsky W L, Yuan F, Roberts W G, Griffith L, Torchilin V P and Jain R K 1998 Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl Acad. Sci. USA 95 4607-12
17. Hong S, Leroueil P R, Majoros I J, Orr B G, Baker J R Jr and Banaszak Holl M M 2007 The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem. Biol. 14 107-15
18. Huang S K, Lee K D, Hong K, Friend D S and Papahadjopoulos D 1992 Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice Cancer Res. 52 5135-43
19. Jain R K 1994 Barriers to drug delivery in solid tumors Sci. Am. 271 58-65
20. Jain R K 1999 Transport of molecules, particles, and cells in solid tumors Annu. Rev. Biomed. Eng. 1 241-63
21. Jain R K 2001 Delivery of molecular and cellular medicine to solid tumors Adv. Drug Deliv. Rev. 46 149-68
22. Jain R K 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58-62
23. Kim D H and Rossi J J 2007 Strategies for silencing human disease using RNA interference Nat. Rev. Genet. 8 173-84
24. Kirpotin D B, Drummond D C, Shao Y, Shalaby M R, Hong K, Nielsen U B, Marks J D, Benz C C and Park J W 2006 Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 6732-40
25. Koning G A and Krijger G C 2007 Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery Anticancer Agents Med. Chem. 7 425-40
26. Koukourakis M I, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S and Karkavitsas N 2000 High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours Br. J. Cancer 83 1281-6
27. Krauze M T, Forsayeth J, Park J W and Bankiewicz K S 2006 Real-time imaging and quantification of brain delivery of liposomes Pharm. Res. 23 2493-504
28. Lasic D and Martin F 1995 Stealth Liposomes (Boca Raton, FL: CRC Press)
29. Lasic D D and Papahadjopoulos D 1995 Liposomes revisited Science 267 1275-6
30. Leach M O 2001 Application of magnetic resonance imaging to angiogenesis in breast cancer Breast Cancer Res. Treat. 3 22-7
31. Maeda H, Wu J, Sawa T, Matsumura Y and Hori K 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 271-84
32. Marzola P et al 2005 Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents Invest. Radiol. 40 421-9
33. McNeeley K M, Annapragada A and Bellamkonda R V 2007 Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma Nanotechnology 18 385101
34. Mitra A, Nan A, Line B R and Ghandehari H 2006 Nanocarriers for nuclear imaging and radiotherapy of cancer Curr. Pharm. Des. 12 4729-49
35. Oshida K, Nagashima T, Ueda T, Yagata H, Tanabe N, Nakano S, Nikaidou T, Funatsu H, Hashimoto H and Miyazaki M 2005 Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography Eur. Radiol. 15 1353-60
36. Sardanelli F, Iozzelli A, Fausto A, Carriero A and Kirchin M A 2005 Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity Radiology 235 791-7
37. Saul J M, Annapragada A V and Bellamkonda R V 2006 A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers J. Control. Release 114 277-87
38. Schiffelers R M, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu P Y, Scaria P V and Woodle M C 2004 Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res. 32 e149
39. Service R F 2005 Materials and biology. Nanotechnology takes aim at cancer Science 310 1132-4
40. Strijkers G J, Mulder W J, van Heeswijk R B, Frederik P M, Bomans P, Magusin P C and Nicolay K 2005 Relaxivity of liposomal paramagnetic MRI contrast agents Magn. Reson. Mater. Phys. Biol. Med. 18 186-92
41. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S and Nose T 1996 Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients Cancer Res. 56 2185-90
42. Teifke A, Behr O, Schmidt M, Victor A, Vomweg T W, Thelen M and Lehr H A 2006 Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis Radiology 239 351-60
43. Torchilin V P 1994 Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents Immunomethods 4 244-58
44. Torchilin V P 2006 Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 1532-55
45. Turetschek K, Huber S, Floyd E, Helbich T, Roberts T P, Shames D M, Tarlo K S, Wendland M F and Brasch R C 2001a MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation Radiology 218 562-9
46. Turetschek K, Roberts T P, Floyd E, Preda A, Novikov V, Shames D M, Carter W O and Brasch R C 2001b Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model J. Magn. Reson. Imaging 13 882-8
47. van de Wiele P, Dierckx R, Scopinaro F, Waterhouse R, Annovazzi A, Kolindou A and Signore A 2002 Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma Breast Cancer Res. Treat. 72 279-86
48. Weissing V, Babich J and Torchilin V 2000 Long-circulating gadolinium loaded liposomes: potential use for mangetic resonance imaging of the blood pool Colloids Surf. B 18 293-9
49. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N and Jain R K 1996 Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody Proc. Natl Acad. Sci. USA 93 14765-70
50. Yuan F, Leunig M, Huang S K, Berk D A, Papahadjopoulos D and Jain R K 1994 Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res. 54 3352-6
51. Zalipsky S 1993 Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes Bioconjug. Chem. 4 296-9